Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters

Relevance of blood-based biomarkers is increasing into the neurodegenerative diseases field, but data on Parkinson's disease (PD) remain still scarce. In this study, we used the SiMoA technique to measure serum content of total tau protein and amyloid-β peptides (Aβ-42, Aβ-40) in 22 PD patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Schirinzi, Tommaso, Zenuni, Henri, Grillo, Piergiorgio, Bovenzi, Roberta, Guerrera, Gisella, Gargano, Francesca, Pieri, Massimo, Bernardini, Sergio, Biagio Mercuri, Nicola, Battistini, Luca, Sancesario, Giulia Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914101/
https://www.ncbi.nlm.nih.gov/pubmed/35280296
http://dx.doi.org/10.3389/fneur.2022.748599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914101/
https://www.ncbi.nlm.nih.gov/pubmed/35280296
http://dx.doi.org/10.3389/fneur.2022.748599

Ejemplares similares